Forty-hertz light stimulation does not entrain native gamma oscillations in Alzheimer's disease model mice

Marisol Soula1, Alejandro Martín-Ávila2,3, Yiyao Zhang1

  • 1Neuroscience Institute, Langone Medical Center, New York University, New York, NY, USA.

Nature Neuroscience
|March 6, 2023
PubMed

Insights

Investigating 40-Hz flickering light for Alzheimer's disease (AD), this study found it did not entrain brain gamma oscillations or reduce amyloid-beta plaques in mouse models. The light was avoided by mice, indicating it may not be a viable noninvasive AD therapy.

Area of Science:

  • Neuroscience
  • Biomedical Engineering
  • Gerontology

Background:

  • Alzheimer's disease (AD) is a neurodegenerative disorder characterized by amyloid-beta (Aβ) plaques.
  • Noninvasive methods to ameliorate AD are in high demand.
  • Gamma oscillations are implicated in cognitive function and AD pathology.

Purpose of the Study:

  • To investigate if 40-Hz flickering light can entrain gamma oscillations in the brain.
  • To determine if 40-Hz light stimulation reduces amyloid-beta burden in AD mouse models.
  • To assess the efficacy of visual flicker stimulation for modulating neural activity in deep brain structures.

Main Methods:

  • Multisite silicon probe recordings in the visual cortex, entorhinal cortex, and hippocampus of APP/PS1 and 5xFAD mice.
  • Immunohistochemistry and in vivo two-photon imaging to analyze plaque count and microglia morphology.
  • Measurement of amyloid-beta 40/42 levels.
  • Assessment of mouse behavior and cholinergic activity.

Main Results:

  • 40-Hz flickering light did not engage native gamma oscillations in the studied brain regions.
  • Spike responses in the hippocampus were weak, indicating poor entrainment of deep structures.
  • Mice exhibited avoidance of 40-Hz light, correlated with elevated hippocampal cholinergic activity.
  • No significant reduction in plaque count, altered microglia morphology, or decreased amyloid-beta levels were observed.

Conclusions:

  • 40-Hz flickering light stimulation is not effective in entraining gamma oscillations or reducing amyloid-beta pathology in these AD mouse models.
  • The observed behavioral avoidance and lack of deep brain structure engagement suggest limitations for this noninvasive approach.
  • Visual flicker stimulation may not be a viable therapeutic strategy for modulating deep brain activity or treating Alzheimer's disease.

Related Concept Videos